2021 Lead Sponsor
2021 Executive Sponsors
2021 Associate Sponsors
2021 Showcase Sponsors
2021 Supporting Sponsors
Supporting/Educational Partner
2021 Media Partner
Overview
IO360˚convenes stakeholders spanning the science and business communities to report on the latest data impacting immuno-oncology to fight a wider range of cancers.
The 7th Annual Immuno-Oncology 360° Delivers Three Key Benefits:
- Access to KOLs driving the science
- Partnership opportunities with all stakeholders in Immuno-Oncology
- Presentations on the latest data affecting the science, clinical and business advancements in Immuno-Oncology
Leaders Among Leaders
Biotech CEO Leadership on the Business
and Science of Cell and Gene Therapy
2021 Strategic Leadership

2021 Key Topic Areas
|
|
|
|
|
|
|
|
|
|
|
|
Immuno-Oncology 360° reports on the most current data and rapid advancements to help IO stakeholders:
|
|
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Join the conversation early and become part of the IO360° community by following us on LinkedIn and by following the conference hashtag #IO360nyc. If you are interested in participating in the 7th Annual Immuno-Oncology 360° 2021 program, please contact us at service@tcfllc.org. Thank you.
Sincerely,
Testimonials
"By bringing together groups such as scientists, investors, and experts in clinical trial design and logistics, it creates a forum where there’s quite a lot of folks participating who are not traditionally talking to one another on a daily basis."
- Roy Baynes, MD, PhD, Merck
"I really enjoyed it and connecting with some really interesting and inspiring people with whom I'm sure this is just the beginning of long standing interactions."
- Jacqueline Karmel, Roche
"Thank you again for the amazing invitation, it was truly my pleasure to be able to participate in the excellent event you organized."
- Christine Ward, BMS
"IO360° was one of the best immuno-oncology meetings I’ve been to. Kudos! Great speakers and great dialogue!"
- Jim Mansfield, PerkinElmer
"Congratulations again on the excellent program for the Immuno-Oncology 360° meeting. It was truly well coordinated and the topics were fantastic!"
- Gilson Baia, PhD, Champions Oncology
"Really good, well-rounded and novel content. Congratulations on filling the house beyond capacity and for securing such an impressive speaking faculty."
- Eileen Daniels, Nektar Therapeutics
"Thank you for a great conference!"
- Elena Spanjaard, Pfizer
"Your team did a wonderful job in putting together an interesting and relevant program."
- Lew Bender, Intensity Therapeutics
"It was a great conference and I was happy to be a part of it."
- Anna Pavlick, DO, MD, NYU Cancer Center